Immunodominance of Lytic Cycle Antigens in CD4+ T Cell Responses to Epstein-Barr Virus
Author Information
Author(s): Adhikary Dinesh, Behrends Uta, Boerschmann Heike, Pfünder Andrea, Burdach Stefan, Moosmann Andreas, Witter Klaus, Bornkamm Georg W., Mautner Josef
Primary Institution: Clinical Cooperation Group, Institute for Clinical and Molecular Biology, GSF-National Research Center for Environment and Health, Munich, Germany
Hypothesis
What are the specific targets of CD4+ T cells in LCL-stimulated T cell preparations against Epstein-Barr virus?
Conclusion
The study found that structural antigens of Epstein-Barr virus are the main targets for CD4+ T cells in LCL-stimulated T cell preparations.
Supporting Evidence
- CD4+ T cell lines from EBV-infected donors responded primarily to lytic cycle antigens.
- Presentation of lytic cycle antigens was impaired by acyclovir treatment.
- Latent cycle antigens were not the main targets for CD4+ T cells in this study.
- Responses against lytic cycle antigens were maintained over extended periods of culture.
Takeaway
This study shows that the immune cells that fight the Epstein-Barr virus mostly target parts of the virus that are active during its lytic cycle, not the parts that are hidden when the virus is dormant.
Methodology
The researchers generated T cell lines from 21 donors and analyzed their responses to various EBV antigens using LCL stimulation.
Potential Biases
Potential bias in donor selection and the limited diversity of the donor population may affect the generalizability of the findings.
Limitations
The study did not explore the full range of potential T cell responses to all EBV antigens and focused primarily on lytic cycle antigens.
Participant Demographics
Participants included five cord blood donors, eight patients with infectious mononucleosis, and eight healthy adult volunteers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website